Unkleaboki Your top choice for funny memes, breaking news, and weird stories

WHO: Amazing Dexamethasone cuts covid-19 deaths

WHO Welcomes Dexamethasone in Treating Critically COVID-19 Patients

The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill COVID-19.

For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared WHO.

The benefit was only seen in patients seriously ill COVID-19, and was not observed in patients milder disease.

“This is the first treatment to be shown to reduce mortality in patients COVID-19 requiring oxygen or ventilator support,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.https://www.nairaland.com/5936558/welcomes-use-dexamethasone-treating-critically

“This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.”Dexamethasone WHO

Dexamethasone is a steroid that has been used since the 1960s to reduce inflammation in a range of conditions, including inflammatory disorders and certain cancers.

It has been listed on the WHO Model List of Essential Medicines since 1977 in multiple formulations, and is currently off-patent and affordably available in most countries.

The researchers shared initial insights about the results of the trial WHO, and we are looking forward to the full data analysis in the coming days.

WHO will coordinate a meta-analysis to increase our overall understanding of this intervention. WHO clinical guidance will be updated to reflect how and when the drug should be used in COVID-19.

Today’s news builds off the WHO Research & Development Blueprint meeting, which took place in Geneva in mid-February to accelerate health technologies for COVID-19, where further research into the use of steroids was highlighted as a priority.

The findings reinforce the importance of large randomized control trials that produce actionable evidence. WHO will continue to work together all partners to further develop lifesaving therapeutics and vaccines to tackle COVID-19 including under the umbrella of the Access to COVID-19 Tools Accelerator.

 

Dexamethasone

Dexamethasone: a long way to go in Coronavirus war.

The government’s public-health performance may not look good, but Britain’s scientists are still top-notch when it comes to inventing and discovering drugs.

On June 16th researchers at the University of Oxford announced that they had identified the first drug proven to reduce mortality from covid-19.

https://www.economist.com/britain/2020/06/20/dexamethasone-cuts-covid-19-deathsDexamethasone, a cheap steroid, reduces deaths by a third among the most severely ill patients.

It is set to become the standard of care for the National Health Service (nhs) across Britain. Doctors around the world will, undoubtedly, follow suit.

The results came from recovery (randomised evaluation of covid-19 therapy), the world’s biggest clinical trial for covid-19 drugs.

The trial, run by Oxford and the nhs, is testing a range of drugs on covid-19 patients in 176 hospitals across Britain. Dexamethasone is an anti-inflammatory that is already used to treat a variety of health problems, such as rheumatoid arthritis, eczema, asthma and some cancers.

It was included in the covid-19 trial because steroids were tried as a treatment for sars (severe acute respiratory syndrome), a related lung disease.

The cheap steroid dexamethasone has been hailed as a “major breakthrough” in the fight against COVID-19 after it was found to reduce deaths by up to a third among patients on ventilators. Everything is hopefully going on well.

The drug is readily available in hospitals and should now become “standard of care” in COVID-19 patients on ventilators or oxygen, researchers say.

The NHS will make dexamethasone available as treatment for patients on ventilators and oxygen from Tuesday afternoon, meaning everyone who could benefit from the steroid could get it.https://www.sciencefocus.com/news/low-cost-steroid-dexamethasone-a-major-breakthrough-in-cutting-covid-19-deaths/

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.